Existing recommendations regarding the discontinuation of co-trimoxazole in children in resource-limited settings are informed in part by observational data from high-income countries,where serious bacterial infections are less frequent, malaria is rare, and co-trimoxazole is primarily used to prevent P. jiroveciipneu across ages